This is a category taken from the full feed of Musculoskeletal and Arthritis news provided by ARMA's members.

International

Eular_standard_logo--1-First awarded in 1975, the Edgar Stene Prize was created by EULAR in honour of Edgar W Stene. The founder and Secretary-General of the Norwegian Rheumatism Association, Edgar Stene also lived with Ankylosing Spondylitis.

The competition for the Edgar Stene Prize 2016 is currently open for entries on the topic of:

“Living with a rheumatic or musculoskeletal disease (RMD):
How I take action to enjoy life to the full”

The competition invites people to share their personal experiences and their individual coping strategies to ‘live life to the full’ despite being affected by a rheumatic or musculoskeletal disease.
What are your top tips on how to live as independently as possible? How can you actively take control of your life and achieve your goals?

The competition is open to everyone living with an RMD (minimum 16 years of age). Each essay should not exceed 2 pages (A4) and be typewritten in Arial 12 point with single line spacing in Microsoft Word (PDFs will not be accepted). The deadline for submitting essays to the ARMA office is 31st December 2015.
Please submit the essays to projects@arma.uk.net. For the detailed prize rules, and to read the entries from the 2015 competition, see here.

As the UK’s member organisation of EULAR -PARE we will appoint a judging panel to decide upon the one essay we will submit to the competition on behalf of the UK. Please let us know if you would like to be part of the judging panel by emailing projects@arma.uk.net by 31st December 2015.
The overall Stene Prize winner will be announced by 15th March 2016.

The Stene Prize winner will be awarded a prize of € 1,000 and will be invited to attend the Opening Plenary Session of the EULAR Congress in London (June 2016). All travel and accommodation will be provided. The runner up will be awarded €700 and the essay in third place will win €300.

Visit the EULAR website for more information.

BJD-squareThe Bone & Joint Decade is moving forward by renaming itself The Global Alliance for Musculoskeletal Health. This better represents what it is – organisations coming together in countries around the world to make musculoskeletal health a priority. It continues to be led by an International Coordinating Council with networks of organisations working together at a national level around the world. ARMA is the National Alliance for the UK and acts as an exemplar of what is needed in each country.

National Alliances such as ARMA are the formal voting members of the Global Alliance but regional and international organisations will be able to join the Alliance so that we can all work together on the common mission of gaining priority for musculoskeletal health. The first Annual General Meeting of the Global Alliance will be held in Oslo at the time of the World Network Conference, 8th and 9th October 2015. For further information see http://www.bjd2015.com/

FSEM-website-logoThe Faculty of Sport and Exercise Medicine UK (FSEM) welcomes a new bill by the French National Assembly requiring GPs to prescribe exercise for patients with diabetes, cancer or cardiovascular disease via publicly funded sports clubs.

According the World Health Organisation (WHO) physical inactivity is one of the leading risk factors for health and is estimated to attribute to one million deaths (about 10 % of the total), per year in the WHO European Region. More than half of the Region’s population is not active enough to meet health recommendations – 30 minutes/day of moderate activity on most week days.*

Dr Roderick Jaques, President of the Faculty of Sport and Exercise Medicine UK comments:
Addressing the prevention, management and recovery from disease through prescribed exercise provides a fresh approach to avoidable diseases like cancer, diabetes, heart disease and many common musculo-skeletal conditions.

“There is no better place to start this process than in GPs surgeries, where most people go for ongoing advice and treatment. The Faculty of Sport and Exercise Medicine would welcome a similar approach in the UK ensuring that patients are not only screened for physical activity levels at their GP surgeries, but their health and the prevention of disease is actively managed via the therapeutic use of physical activity and exercise.”

The French bill comes at a time when physical inactivity is beginning to be recognised as a key health threat in the UK and across Europe, equivalent to smoking and alcohol abuse**. The trend in the region is towards less activity, whilst non-communicable disease and obesity continues to increase.

Physical activity resources for GPs and health professionals are becoming increasingly available in the UK, following the publication of NICE guidelines in
2013 –  Physical Activity Brief Advice for Adults in Primary Care:

  • Public Health England has funded a new BMJ e-learning module on physical activity, including the prevention and treatment of many common diseases
  • Motivate 2 Move, created in association with the Wales Deanery and Cardiff University, was launched last year to encourage GPs to educate, motivate and encourage patients about the benefits of physical activity

References:

*10 key facts on physical activity in the WHO European region.
**The FSEM The Nation’s Hidden Health Threat April 2015.

Resources:
BMJ e-learning modules physical activity
Motivate 2 Move
NICE – Physical Activity Brief Advice for Adults in Primary Care
For further information view the FSEM’s Manifesto – Making the Physically Active Choice.
For further evidence of the effectiveness of exercise medicine in treating common diseases and conditions view –A Fresh Approach NHS information documents.
Follow the twitter conversation – GPs and physical activity using #GPs #prescribeexercise @FSEM_UK

euro-parliamentx200The Scleroderma Society will be hosting an event at European Parliament on the 30th June 2015 to tackle inequity of care and treatment for scleroderma patients across Europe.

The event will run from 9:30am until 12:00 with patients, scleroderma specialists and hopefully key decision makers speaking at the event. If you are interested in attending please contact Amy Baker.

If you are unable to attend please sign our Call to Action.

Roadmap-for-sustainable-healthcare-squareThe Sustainable Healthcare initiative was launched in 2013. It sought to address the environment of demographic change and economic constraints facing European healthcare systems, and to counter solutions which focus purely on cutting headline treatment costs.

You can read about the the conference and European Steering Group on Sustainable Healthcare (ESG) and read the full Sustainable Healthcare White paper from Abbvie: “Acting Together: A Roadmap for Sustainable Healthcare“.